SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 1,726.50 |
Enterprise Value ($M) | n/a |
Book Value ($M) | 2,862.57 |
Book Value / Share | 43.44 |
Price / Book | n/a |
NCAV ($M) | 2,249.80 |
NCAV / Share | 34.14 |
Price / NCAV | n/a |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | 0.07 |
Return on Assets (ROA) | 0.05 |
Return on Equity (ROE) | 0.07 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 9.95 |
Current Ratio | 10.13 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 3,559.43 |
Assets | 4,172.20 |
Liabilities | 1,309.63 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Similar Companies | |
---|---|
GDERF – Galderma Group AG | GFOO – Genufood Energy Enzymes Corp. |
GIFLF – Grifols, S.A. | GLUC – Glucose Health, Inc. |
GNCAQ – Genocea Biosciences, Inc. |
Financial data and stock pages provided by
Fintel.io